Form D · Other Health Care
Cerebral Therapeutics, Inc.
Aurora, CO · CIK 0001744709
Offering snapshot reported Jan 17, 2020 · SEC filing
- Reported sold
- $20M Offering amount: $35M
- Investors reported
- 6 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jan 6, 2020 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 17, 2020 | Initial | $19,999,998 | No comparison | 6 | SEC filing |
| Mar 20, 2019 | Amendment | $11,000,000 | $7,996,795vs Jun 27, 2018 | 4 | SEC filing |
| Jun 27, 2018 | Amendment | $3,003,205 | $503,205vs Jun 25, 2018 | 2 | SEC filing |
| Jun 25, 2018 | Initial | $2,500,000 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-358324
Source: Form D, filed Jan 17, 2020. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Daniel Abrams | Director, Executive |
| Stephen Farr | Director |
| Matthew Hammond | Director |
| Warren Lammert | Director |
| Shah Mahendra | Director |
| Weston Nichols | Director |
| Mahendra Shah | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
12635 E. Montview Blvd. Suite 149
Aurora, CO, 80045
Aurora, CO, 80045